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Human monoamine oxidases A and B were expressed under the control of a galactose inducible promoter in Saccharomyces cercvisiae. The two 
MAO isoenzymes were found located in the yeast mitochrondrial outer membrane, probably in different orientations as suggested by controlled 
proteolysis experiments. A high level of both human MAO-A or-B activities is measured in intact mitochrondria without the need for any detergent 
solubilisation step. The substrate and inhibitor selectivities of the membrane-bound MAOs are highly similar to those of purified human enzymes. 
The level of MAO-B activity, however, is selectively lowered when bound to the membrane. 
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1, INTRODUCTION 
Monoamine oxidases (MAO, EC 1.4.3.4) are higher 
eucaryote integral proteins of the outer mitochondrial 
membrane. These flavoenzymes catalyze the oxidative 
deaminations: 
R-CHzNH; + 02 -I- H7,O - R-CHO -i- H202 + NH; 
of several exogenous and endogenous amines in various 
tissues [11. Two isoenzymes, encoded by separate genes 
[2,3], and having different substrate preferences and in- 
hibitor specificities are responsible for human MAO ac- 
tivity. MAO-A oxidizes vasoactive and neuroactive 
amines, such as serotonin, and is preferentially inac- 
tivated by the acetylenic inhibitor clorgyline. MAO-B 
metabolizes xenobiotic amines and is preferentially in- 
activated by pargyline (4-61, 
In almost all human tissues, MAO activity consists of 
a mixture of both forms of the enzyme; although 
placental tissue contains predominantly MAO-A and 
platelets mainly MAO-B [ 1,7]. The difficulty in obtain- 
ing large amounts of a pure MAO form from human 
sources and the tow expression level in transfccted 
mammalian cells (81, makes heterologous expression in 
yeast a tempting alternative. Very recently, the human 
A-isoenzymc was expressed and purified from 
transformed yeast cells, but no data were provided con- 
cerning its subcellular location and functionality in the 
yeast membranes [9]. We extend the study to the B- 
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isoenzyme and investigate the MAO membrane loca- 
tions and functionalities in yeast cells. The effects of the 
membrane environment on MAO activities are also 
analyzed since the lipid composition was described to 
have an influence [l, lo]. Part of this work has been 
presented before in preliminary form [l 11, 
2. MATERIALS AND METHODS 
Chemicals were purchased from Sigma. Thermus aquaticus DNA 
polymerase was from Bioprobe Systems. Oligonucleotides were syn- 
thesized on a MilliGen 7500 DNA synthesizer and purified by DEAE- 
Sephacel (Pharmacia) chromatography and repeated ethanolic 
precipitations. PCR amplifications were performed using standard 
conditions de!;cribed previously [12]. The Saccharongvces cerevisiae 
W303,IB strain (MATa, Ieu2, l1is3, trpl, ~ru3, a&Z-l, can”, cyr”‘) 
was provided by Dr P. Netter. The expression plasmid pYeDPl/g-2 
was described previously [13]. The human cDNA encoding MAO-A 
was obtained as pHM 1 I plasmid [3 1, The DNA fragment cncompass- 
ing the human MAO-B coding sequence was obtained by using PCR 
amplification from adult human liver total mRNAs. This DNA frag- 
ment was cloned Into the Xbal-Pstl sites of Bluescript II-KS vector 
(Stratagene) yielding the BSMAOB plasmid. Sequencing of the PCR- 
amplified material revealed that only 2 base pairs (bp) differ from the 
published scqucncc 121, each in the 3’.non-coding region. 
Culture media SWAS (containing galacrosc) and SWA6 (containing 
glucose), spheroplast prcpararion by enzymatic digestion of yeast cell 
walls, and subcellular fractionations were described previously 
(13,141. A crude mitochondrial fraction resulting from about 4 x IO’ 
ccllr was resuspended in 2 ml of SO mM Tris.HCI buffer pH 7.4 con- 
taining I tnM EDTA, 0.6 M sorbitol and 25% double&tilled 
glycerol, end cuntrifugcd for 3 min at 3000 rpm in a microcentrifuge, 
the pellet was discnrded and the supernatnnt ccnttifugcd again for 
6 t?iin ;11 IO000 rpw. Tire mitochondrial pellc~ wag resuspended and 
the mm operation repeated twice. The final purified mitochondrial 
pellet was rerunpeadcd in the same buffer at 3-5 mg protein/ml, md 
kept (roaen nt -70%’ for wceka without any detectable change in 
MAQ activtty. 
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Serotonin deaminase activity was assayed in a l-ml assay mixture of 
50 mM phosphate buffer pH 7.5 containing 0.1 mM serotonin, and 
the mitochondrial aliquot (10 fig of protein). After a IO-min incuba- 
tion at 37”C, the reaction was quenched by the addition of 0.1 ml 6 M 
NCI. The reaction product was extracted with 1 ml of 
ethylacetate/toluene (1: I, vol/vol), and quantified by its fluorescence 
emission spectrum between 330 and 400 nm (excitation wavelength 
289 nm). Kynuramine deaminase activity (MAO-A) and benzylamine 
deaminasc activity (MAO-B) were measured as described [15] using 
15-30 gg of protein, Protein concentrations were determined by the 
Pierce BCA protein microassay using bovine serum albumin as a stan- 
dard. 
reformatting of the heterologous cDNA by removing all 
The digitonin solubilization of mitochondrial outer membrane pro- 
teins was carried out by mixing the sample (0.3 mg proteins) with an 
equal vo1um.e of 2% digitonin in 50 mM Tris-I-ICI buffer pN 7.4, 
1 mM EDTA, and then incubating the mixture for 10 min at 37°C. 
The suspension was then centrifuged for 10 min at 10000 rpm. The 
supernatant contains the digitonin-solubilized proteins, while the 
pellet contains membranes. Clorgyline and pargyline titrations of 
mitochondrial aliquots were performed by incubating 20-40 pg pro- 
teins with various concentrations of acetylenic inhibitor for 15 min at 
37’C. 100% relative activity corresponds respectively to 42 and 
5 nmol of substrate/min/mg proteins for MAO-A and MAO-B 
assays. 
Controlled proteolysis using Proteinase K (Boehringer) on yeast 
mitochondria (0.2 mg proteins) was carried out in 0.25 ml of iso- 
osmotic buffer, Tris-HCI 50 mM pH 7.4, I mM EDTA, 0.6 M sor- 
bitol, 25% glycerol. Incubations with GO fig or 2OOltg Proteinase K 
per mg of mitochondrial protein were at 37°C for 45 min. Control ex- 
periments were run in parallel without Proteinase K. MAO activities 
were normalized using cytochrome c oxidase activity [16] as a 
reference. 
3. RESULTS AND DISCUSSION 
3.1. Construction of yeast strains expressing human 
MAO-A and -& _ 
Heterologous expression in yeast cells requires the 
the 5 ‘-non-coding sequence prior to insertion into the 
yeast. expression vector. This last step maximizes the 
level of expression, as previously shown [13,14]. The 
BstI.JI-EcoRI 1880 bp fragment of pHMl1 [3] that in- 
cludes the MAO-A coding sequence minus the first 28 
nucleotides, and 300 bp of the 3’-non-coding sequence, 
was ligated with the synthetic oligonucleotide: ATG- 
6A&AAcCAAGAAAA@GCTTeTATCG in order to 
restore the full length coding sequence. Nucleotides 
modified so as to match the yeast codon bias are 
underlined. These substitutions do not change the 
deduced amino acid sequence. The resulting 1910 bp 
fragment formatted as a Bg/II-EcoRI cassette was in- 
serted between the Band-II and EcoRI sites of 
pYeDP1 /S-2 expression vector, to give pHMAOAV8. 
PCR amplification using primers deduced from the 
published sequence [%] was used to extract the MAO-B 
cDNA coding sequence from pB§MAOB. This pro- 
cedure introduces a &/II site immediately upstream of 
the start codon ATG and a second Bg111 site overlapp- 
ing partially TAA stop codon at the 3’-end. The 
resulting Bg&I cassette was inserted into the BarnHI site 
of pYeDP1/8-2 expression vector in the proper orienta- 
tion yielding pHMAOBV8 (see Fig. 1). 
3.2. Subce/lukr focation of HMAO-A and -B ex- 
pressed in yeast ceils 
W303.1B yeast cells transformed by plasmids 
HMAOAV8 and HMAOBV8 were selected for growth 
on uracil-depleted minimal medium containing glucose. 
The expression of the heterologous MAO genes was 
Pig. I. Conslructa fop expression of human MAOs in yeast, ln the MAO-A esprcrxion construct, the 1907 bp insert is composed of the 28 bp 
synthetic 5’.coding sequence (black box), the I556 bp remaining coding requcncc, end n 3’.non.ceding sequence [hatched box). In lhc h1AO.U 
expression construct1 the insert ix rompoard UP the IS60 bp rndfng rcquence including the stop codon. B, G end E, rcrgectivety stand for t3anrCII, 
Up/II and fZco#l. 
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Table I 
Subcellular locations of yeast-expressed human MAOs 
July 1991 
Substrate Yeast Activity in 
Mitochondria Microsomes Cytosol 
Serotonin Expressing MAO-A 50.0 
(45 000) (5:;:) &I& 
Control go.01 GO.01 GO.01 
Benzylamine Expressing MAO-B 
(14::O) (3Z) 
0.15 
(2500) 
Control < 0.06 < 0.03 GO.03 
Specific activities are in nmol/min/mg protein. Vaiues between brackets are total 
MAO activities (in pmol/min/4 X 10’ cells). 
started by replication on galactose-containing plates, 
followed by well-aerated culture in SWAS liquid 
medium. Cell lysis was performed under mild and iso- 
osmotic conditions, after digestion of the cell wall by a 
mixture of lytic enzymes. During the purification pro- 
cedure, particular caution was taken to avoid physical 
damage to mitochondria (see section 2). The different 
subcellular fractions were isolated and examined for the 
typical serotonin and benzylamine deaminase activities 
of hume.n MAO-A and -B, respectively. Table I in- 
dicates that a high level of the corresponding MAO ac- 
tivities is found in yeast mitochondrial fractions when 
cells are transformed to express either A- or B- 
isoenzyme. On the contrary, mitochondria from con- 
trol yeast did not exhibit any detectable MAO activity 
when tested with the same substrates. On the basis of 
the turn-over numbers determined on purified human 
placental MAO-A or bovine liver MAO-B [15], a 
mitochondrial content of, respectively, 520 and 
25 pmol per mg protein can be estimated. The total 
mitochondrial activity represents 88% of the total 
cellular activity for MAO-A and 72010 of that for MAO- 
B. We thus conclude that both MAO isoenzymes are 
functionally expressed and localized mainly in yeast 
mitochondria. This situation is highly reminiscent of 
the human case [17]. 
In order to test the submitochondrial location(s) of 
MAOs and the influence on their activities of the mem- 
brane environment, we carried out the disruption of 
mitochondrial outer membrane by digitonin [ 181. Such 
a treatment results in the apparent solubilization of 
most if not all the deaminase activities (Table II), in- 
dicating an outer membrane location in yeast for the 
two human isoenzymes. Surprisingly enough, a 3-fold 
increase in the B, but not A, activity was observed upon 
digitonin solubitization. This observation may be 
related tb the known inhibitory effect selective for 
MADB of phosphatidylserine [19], and points to the 
fact that the mitochondrial membrane containing 
MAO-B is a more physiological model than the purified 
enzyme. 
To further characterize MAO membrane location(s), 
intact mitochondria were submitted to controlled pro- 
teinase K digestions under iso-osmotic conditions. 
Residual activities were standardized in order to correct 
them for artifacts due to damaged mitochondria by us- 
ing cytochrome c oxidase activity as a reference. Fig. 2 
shows that both MAO-A and -B are partially sensitive 
to limited proteolysis suggesting an outer side location. 
Moreover, a differential behaviour between MAOs was 
observed when similar analyses were performed at two 
concentrations of proteinase K. The results suggest that 
if both MAOs partition between the two sides of the 
outer membrane, MAO-B seems mainly located on the 
outer face. However, the slightly different behaviours 
between the MAOs observed in this study, made in the 
same membrane context (yeast mitochondria), are con- 
sistent with the previous hypothesis concerning the 
relative orientation of MAO-A in human mitochondria 
from brain cortex (synaptosomal and non- 
Table II 
Digitonin trentrnettt of MAOexpressing yew mitochondria 
144 
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60 2cm 
Proleinase K 
(mg 19 of mitochondrial protein) 
Fig. 2. Controlled proteolysis in iso-osmotic conditions on yeast 
mitochondria expressing MAOs. A refers to the A-isoenzyme, B to 
the B isoenzyme. 
synaptosomal), and of MAO-B from liver [20]. The 
mitochondrial addressing of MAOs in yeast hus seems 
to be similar to that in the human. 
3.3. Substrate and inhibitor specificities of membrane- 
bound MAOs 
Most of the MAO substrates and inhibitors are 
relatively hydrophobic and accumulate preferentially in 
the membrane phase. Moreover, detergent solubiliza- 
tion of MAOs for purification purposes was reported to 
affect their kinetic properties [21]. Therefore, we ques- 
tioned the possible role of the membrane on human 
MAO activities expressed in yeast. The mitochondrial 
fractions containing MAOs were tested for typical 
serotonin (MAO-A) and benzylamine (MAO-B) ac- 
tivities without a solubilization step and in the same 
cellular context (yeast cells), contrary to usual kinetic 
studies made with the purified form from either human 
placenta (MAO-A) or bovine liver (MAO-B). In Table 
III the obtained steady-state parameters are compared 
with data reported for MAO purified from human 
tissues [4,22], or expressed in transfected COS cells [$I. 
For both MAOs the measured K,,, values are similar, 
flme (min) 
0 4 16 20 
Fig. 3. Time courses of kynuramine (MAO-A) and benzylamine 
(MAO-B) deaminations using yeast mitochondria. For both panels, 
the 2 min arrow indicates the addition of the mitochondrial aliquot: 
traces 1 to 3, 20 pg (MAO-A) or 50 cg (MAO-B) of protein; trace 4 
(control yeast) 6Opg proteins, Additions at 8 min were: trace 1, 
buffer (MAO-A and-B); trace 2, pargyline final cont. 94pM (MAO- 
A) or clorgyline final cont. IOpM (MAO-B); trace 3, clorgyline final 
cont. 9 ,&l (MAO-A) or pargyline final cont. 19 pM (MAO-B). 
whatever the system considered. In contlcast, Vm values 
per mg of protein are at least lo-fold higher in yeast 
mitochondria than in the other systems. This can be in- 
terpreted either as a higher expression level or as an im- 
Table I11 
Steady-state parameters dctcrmincd with yeast mitochondrial fraction 
Ellsyme Source of mitochondria 
YCilSP Human tissue cos ccllrb 
MAO-A (serotonin) Km (ill /N) IO0 t la 9s’ 
L’“Wd” so &3 0.8” 0,2 
MAO-8 (bcnzyletirine) KS (in PM) CO 110 G4c 
I/o,*J 6.4 I 0.6’ 0,6”*‘.t n,2*** 
Coniparixon with hutncrn FvlAOx rrm other sources. a, this work; b, ref. [S]; c, rcr. (22); d, 
r,;,,* flue is expreebecl in nnrol/mln/mg protcln; c, incubationr itt 37’C; r, incubalionr ~1 
24X; g, piic~icltiylnnrinc ax substrate. 
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